Using the Oncomine database, we compared MAP2K transcription in 20 cancers and normal tissues: mRNA expression of MAP2K1/3/4/6 was significantly lower, and MAP2K2 was significantly higher, in LIHC tissue (P < .05) (Fig. 1 and Table 1). This evidence concerns the gene MAP2K2 and cancer.